Thanks for picking up my typo. so your completion date of 25.06.22 was this the date stated at the time of the first patient dosed ? I only ask as we were promised an update 2 quarters ago then bumped to last quarter. Now this quarter maybe. As you pointed out i clearly am no expert so throw me a bone with your expert knowledge, it was recently pointed out that my stupidity and ignorance allowed me to miss the obvious FACT that from day one of first patient dosed with cf33 we needed to use it in combination with a cd19 yet are we well over 24 months since first patient dosed with cf33. At what date post the 1 cr ( the first patient dosed) did we realise we needed to buy our azercell? For cf33 to work? So they had zero obligation to report the cr? Yet they did, olong with the progression or lack of, of the other 39 patients in that first cohort. Though as made clear they had no obligation they did. This set a precedent did it not? Why no more un obligation updates? I live in Darwin but when LC stated she didnt know why the sp had fallen so dramatically i swear i could hear every long term holder slap their foreheads from all the way up here. I very sincerely look forward to your educated reply as im sure im not the only long termer constantly bewildered.
IMU Price at posting:
3.9¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)